Pharmena opens a unit in Germany
23:15
Pharmena established a special purpose company Menavitin in Germany. Menavitin will sell dietary supplements containing 1-MNA on the German, Austrian and Swiss markets, Pharmena said. It owns 92.5 percent shares in Menavitin, and the remaining 7.5 percent belong to Fritz Oesterle. For over 12 years he was CEO Celesio AG, a European distributor of pharmaceuticals.
